To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task…

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N94020D00005
Awardee
Awarding agency
Task orders
2 $405,699 obligated

Award facts

Combined order value
$404,017 Current and potential, with all options
Last date to order 89% complete
IDV ceiling 8% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 18 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Child Health and Human Development awarded a multiple-award indefinite-delivery contract to The Trustees of The University of Pennsylvania on August 1, 2020, with a ceiling of $5,000,000 and an ultimate completion date of July 31, 2027. The IDIQ funds Phase I, II, III, and IV contraceptive trials in women, treatment trials of gynecologic conditions including endometriosis and leiomyomata, and development of research protocols on a task order basis.

Place of performance is Philadelphia, Pennsylvania. Work is severable in nature.

Under this IDIQ, NICHD issued a delivery order to the University on August 1, 2020, valued at $87,736.46 for core function activities supporting the NICHD Contraceptive Clinical Trials Network female sites, including protocol review, protocol development, and support for past, present, and future Contraceptive Clinical Trials Network activities. A subsequent delivery order issued September 28, 2023, valued at $316,280.79, funded the OVAPRENE Phase 1 effort—protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the OVAPRENE vaginal device clinical trial, with performance at Philadelphia, Pennsylvania and an ultimate completion date of May 30, 2025.

Both delivery orders are priced on a cost-no-fee basis. The originating pre-solicitation was posted May 7, 2019, with an award date of July 28, 2020.

Description

To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 · Nichd: r & d: to conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or… $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N94020D00005?

75N94020D00005 was awarded to The Trustees Of The University Of Pennsylvania by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.

How much is contract 75N94020D00005 worth?

Orders under 75N94020D00005 have obligated $405,699. Their combined current value, with exercised options, is $404,017. 75N94020D00005's own ceiling is $5,000,000.

How many orders have been placed under contract 75N94020D00005?

2 orders have been placed under 75N94020D00005, the latest on September 28, 2023.

Who can order from contract 75N94020D00005?

75N94020D00005 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N94020D00005 competed?

The extent of competition for 75N94020D00005 was full and open competition. The government received 18 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV